Brief: Inhalation Sciences To Conduct SEK 1 Mln Cro Study For Major European Pharma Company
05/08/2019 07:06
Aug 5 (Reuters) - Inhalation Sciences Sweden AB ISAB.TE :
* INHALATION SCIENCES TO CONDUCT 1 MSEK CRO STUDY FOR MAJOR
EUROPEAN PHARMA COMPANY
* WORK ON FEASIBILITY STUDY BEGAN IN JUNE 2019 AND IS
EXPECTED TO
RUN UNTIL OCTOBER 2019
Source text for Eikon: ID:nWkr3NJCPH
Further company coverage: ISAB.TE
(Gdynia Newsroom)
((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))
Recent news on Inhalation Sciences Sweden AB
See all newsBrief: Inhalation Sciences Gets Order Of EUR 60,000 From Long-Term Big Pharma Client
Brief: Inhalation Sciences Announces Outcome Of The Rights Issue
Brief: Inhalation Sciences Sweden Q4 Operating Loss Widens To SEK 4.3 Million
Brief: Inhalation Sciences Receives New Order From Aquilon Pharma
Brief: Inhalation Sciences Receives New Order From University Of Vienna